Compare Amylx Pharmaceuticals Inc (AMLX) vs Global X FTSE Southeast Asia ETF (ASEA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Global X FTSE Southeast Asia ETF — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Global X FTSE Southeast Asia ETF trades at $21.47. Which is the better fit depends on your goals.
| AMLX | ASEA | |
|---|---|---|
Market Cap | $2.64B | — |
Sector | Health | Sector/Thematic |
52-Week High | $24.19 | $21.53 |
52-Week Low | $7.82 | $16.86 |
Enterprise Value | $2.39B | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Global X FTSE Southeast Asia ETF
ASEA tracks the performance of the largest companies in Southeast Asia. It provides exposure to key emerging markets including Singapore, Indonesia, Thailand, and Malaysia, with a heavy focus on financials like DBS Group and Bank Central Asia.
Read more on ASEA →
